FAQs

Frequently Asked Questions

FAQs About Cellular Therapy

cellular therapy faqs
When it comes to cellular therapy, people have a number of questions. Here is a list of the frequently asked questions (FAQs) we’ve received:

The Lung Institute is passionate about improving the lives of people living with chronic lung diseases. At the Lung Institute, we offer cellular therapy for people with chronic lung diseases. We understand that every condition is different and that each of our patients has a unique story. Our team of dedicated medical professionals is ready to answer your questions and provide top quality care. Our goal is to help people enjoy their favorite activities, spend more time with their families and grandchildren and breathe easier.

Regenerative medicine is an emerging field of medicine that aims to address the root cause of degenerative diseases that have been considered very difficult to successfully treat. With the medical advancements of regenerative medicine, specialized physicians can use your cells to help promote healing of organs.

Cells are found in multicellular organisms and are the building blocks of life. In fact, cells have the ability to self-renew and replicate.  Autologous cells or adult cells are derived from the patient’s own body.

At the Lung Institute, we specialize in cellular therapy for people living with certain chronic lung diseases, such as chronic obstructive pulmonary disease (COPD), emphysema, chronic bronchitis, pulmonary fibrosis, interstitial lung disease and others. During our cellular therapies, trained medical specialists harvest cells from a sample of a patient’s blood, separate and process them in our on-site lab and then return the cells to the patient intravenously. Once returned to the patient, the cells may begin to promote healing from within the lungs.

At the Lung Institute, many of our patients are surprised at the ease of our cellular therapies. All of our treatments are minimally invasive and outpatient. While everyone’s pain threshold varies, we work hard to make our treatments as pain-free as possible.

To determine if you’re a candidate, we’re happy to offer a complimentary review of your medical records. Our dedicated medical staff are ready to answer your questions and discuss the treatment options available. Feel free to contact us at (800) 729-3065 to speak one-on-one with our medical staff today.

The risk of rejection is very minimal and nearly nonexistent.

Innovations in the field of regenerative medicine are newer and emerging in medical technology. Currently, the highly specialized methods are not taught in traditional medical schools or residency programs. At the Lung Institute, our advanced procedures are specialized, and our physicians receive additional training for the best quality of care for our patients.

COPD affects people differently and at varying rates of progression. Sometimes, doctors may try to estimate life expectancy, but there isn’t a way for anyone to know an exact life expectancy. For some people, COPD progresses rapidly, and for others, COPD progresses slowly over time. Currently, there isn’t a cure for COPD, but there are treatment options available to help people manage symptoms.

Pulmonary fibrosis is a progressive form of lung disease, meaning it will worsen over time. Like COPD, pulmonary fibrosis affects people differently and at varying rates of progression. Doctors may try to estimate life expectancy with pulmonary fibrosis, but there is not a way for anyone to know an exact life expectancy. At this point, there is not a cure for pulmonary fibrosis. However, treatment options are available to help people living with pulmonary fibrosis manage their symptoms.

Like COPD and pulmonary fibrosis, emphysema affects everyone differently and at different rates of progression. While doctors may try to approximate life expectancy for someone with emphysema, there is no way for anyone to know an exact life expectancy. While there isn’t a cure for emphysema, there are various treatment options available to help manage symptoms.

The BODE Index is a way for doctors to place certain lung diseases, such as COPD and emphysema, into stages. The BODE Index accounts for how the disease affects your life.

BODE stands for body mass, obstruction of airflow, dyspnea (difficulty breathing) and exercise capacity.

Body Mass
Obstruction of Airflow
Dyspnea (difficulty breathing)
Exercise Capacity

The Global Initiative for Chronic Obstructive Lung Disease (GOLD) developed the GOLD System. The GOLD System uses the forced expiratory volume in one second (FEV1) measurement from your pulmonary function test to categorize certain lung diseases, such as COPD and emphysema, into stages. There are four total stages in the GOLD System.

Stage 1: Very mild COPD with a FEV1 about 80 percent or more of normal.
Stage 2: Moderate COPD with a FEV1 between 50 and 80 percent of normal.
Stage 3: Severe emphysema with FEV1 between 30 and 50 percent of normal.
Stage 4: Very severe COPD with lower FEV1 than Stage 3, or those with Stage 3 FEV1 and low blood oxygen levels.

See what our patients are saying about their cellular therapy for lung disease.

If you would like to find out more about our available treatment options, please contact one of our patient care coordinators today at (800) 729-3065 to schedule a free consultation.

Related Posts

  • What causes fibrosis of the lungsPulmonary fibrosis is a chronic lung disease that thickens and hardens the lung passageways responsible for carrying oxygen into the bloodstream. It can cause shortness of breath even with minimal ... Read more
  • Does Medical Marijuana Help or Hurt My COPDAccording to the National Conference of State Legislatures, there are currently medical marijuana and cannabis programs in 29 of the 50 states, the District of Columbia, Guam, and Puerto Rico. ... Read more

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.